![](/img/cover-not-exists.png)
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial
Koomen, Jeroen V., Heerspink, Hiddo J. L., Schrieks, Ilse C., Schwartz, Gregory G., Lincoff, A. Michael, Nicholls, Stephen J., Svensson, Anders, Wedel, Hans, Weichert, Arlette, Grobbee, Diederick E.,Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.13862
Date:
October, 2019
File:
PDF, 1.21 MB
english, 2019